Keywords: Treatment-resistant depression; Quality of life; Functional impairment; Childhood adversity; Major depressive disorder; Bipolar disorder; ACE; adverse childhood experience scale; CGI-S; clinical global impression severity scale; ECT; electroconvulsive the
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: Puerperal disorders; Postpartum depression; Postpartum psychosis; Electroconvulsive therapy treatment outcome; CGI-I; Clinical Global Impressions - Improvement scale; CGI-S; Clinical Global Impressions - Severity scale; CI; Confidence interval; DSM; D
Keywords: ANCOVA; Analysis of covariance; C-CASA; Columbia Classification Algorithm for Suicide Assessment; CGI-I; Clinical Global Impressions - Global Improvement; CGI-S; Clinical Global Impressions - Severity of Illness; CRT; Choice Reaction Time; C-SSRS; Col
Keywords: Mania and bipolar disorder; Unipolar depression; ECT; CGI-S; Clinical Global Impression Severity Scale; CI; confidence interval; ECT; electroconvulsive therapy; ICD; International Classification of Diseases; MADRS-S; Montgomery-Ã
sberg Depression Rating S
Keywords: AE; adverse event; CCK; cholecystokinin; CGI; clinical global impression; CGI-I; clinical global impression-improvement; CGI-S; clinical global impression-severity; ChiCTR; Chinese clinical trial registry; CONSORT; consolidated standards of reporting tria
Keywords: ABC; Aberrant Behavior Checklist; ADI-R; Autism Diagnostic Interview-Revised; ASD; autism spectrum disorder; BPI-01; Behavior Problems Inventory-01; CGI; Clinical Global Impressions; CGI-I; Clinical Global Impressions-Improvement; CGI-S; Clinical Global I
Keywords: BPRS; Brief Psychiatric Rating Scale; CGI-S; Clinical Global Impression-Severity of Illness; CP; chlorpromazine-equivalent doses of antipsychotics; DRD2; dopamine D2 receptors; DSP; dopamine supersensitivity psychosis; GAF; Global Assessment of Functionin
Keywords: AE; adverse event; BL; baseline; BMI; body mass index; CGI-C; clinical global impression-change; CGI-S; clinical global impression-severity; CI; confidence interval; DSM-IV; diagnostic and statistical manual of mental disorders-IV; EP; endpoint; EPMS; ext
Keywords: AIS; Athens Insomnia Scale; BZDs; benzodiazepine drugs; BZRAs; benzodiazepine receptor agonists; CBT-i; cognitive behavior therapy for insomnia; CCMD; Chinese Classification and Diagnosis of Mental Disease; CGI; Clinical Global Impression; CGI-I; Clinical
Keywords: AE; Adverse event; AIMS; Abnormal involuntary movement scale; ANCOVA; Analysis of covariance; BARS; Barnes akathisia rating scale; BL; Baseline; BMI; Body mass index; CGI-S; Clinical global impression severity; CI; Confidence interval; C-SSRS; Columbia su
Keywords: ANCOVA; Analysis of Covariance; BDNF; brain-derived neurotropic factor; CGI-S; Clinical Global Impression of Illness, Severity; DSM-IV; Diagnostic and Statistical Manual for Mental Disorders, 4th Edition; GAD; generalized anxiety disorder; HAMA; Hamilton
Keywords: CGI-I; Clinical Global Impressions-Improvement; CGI-S; CGI-Severity of Illness; C-SSRS; Columbia-Suicide Severity Rating Scale; ITT; intent-to-treat; LOCF; last observation carried forward; LS; least squares; LSMD; least squares mean difference; MADRS; Mo
Long-term effectiveness of aripiprazole once-monthly for schizophrenia is maintained in the QUALIFY extension study
Keywords: Aripiprazole once-monthly; Schizophrenia; Maintenance treatment; Quality of life; AE; adverse event; APTS; all-patients-treated set; AOM 400; aripiprazole once-monthly 400Â mg; CGI-S; Clinical Global Impressions-Severity; C-SSRS; Columbia Suicide Severity
Research paperThe safety and tolerability of cariprazine in patients with manic or mixed episodes associated with bipolar I disorder: A 16-week open-label study
Keywords: AIMS; Abnormal Involuntary Movement Scale; BARS; Barnes Akathisia Rating Scale; CGI-S; Clinical Global Impressions-Severity; C-SSRS; Columbia-Suicide Severity Rating Scale; EPS; extrapyramidal symptoms; ITT; intent-to-treat; LOCF; last observation carried
High-frequency repetitive TMS for suicidal ideation in adolescents with depression
Keywords: Adolescent; Brain stimulation; Depression; Suicidality; Suicidal ideation; Transcranial magnetic stimulation; ATHF; Antidepressant treatment history form; CDRS-R; Children's depression rating scale, revised; CGI-S; Clinical global impression-severity scal
Psychometric Validation of the Pulmonary Arterial Hypertension-Symptoms and Impact (PAH-SYMPACT) Questionnaire
Keywords: macitentan; patient-reported outcomes; pulmonary arterial hypertension; symptoms; 6MWD; 6-min walk distance; CAMPHOR; Cambridge Pulmonary Hypertension Outcome Review; CGI-C; Clinician Global Impression of Change; CGI-S; Clinician Global Impression of Seve
Efficacy and safety of the glycine transporter type-1 inhibitor AMG 747 for the treatment of negative symptoms associated with schizophrenia
Keywords: ANCOVA; analysis of covariance; CDSS; Calgary Depression Scale Score; CGI-I; Clinical Global Impressions-Improvement; CGI-S; Clinical Global Impressions-Severity; CSF; cerebrospinal fluid; C-SSRS; Columbia-Suicide Severity Rating Scale; GlyT1; glycine tra
Research paperEfficacy and safety of sublingual ramelteon as an adjunctive therapy in the maintenance treatment of bipolar I disorder in adults: A phase 3, randomized controlled trial
Keywords: AE; adverse event; CGI-S; Clinical Global Impression - Severity; CP; conditional power; DSM-IV-TR; Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision; ECT; electroconvulsive therapy; FAS; full analysis set; HAM-A; Hamil
Short-term open-label chamomile (Matricaria chamomilla L.) therapy of moderate to severe generalized anxiety disorder
Keywords: Chamomile; Generalized anxiety disorder; Anxiolytic; Herbal; Botanical; Alternative and complementary medicine; BAI; Beck Anxiety Inventory self-report scale; CGI-S; Clinical Global Impression-Severity; GAD; Generalized Anxiety Disorder; HAM-A; Hamilton
Long-term chamomile (Matricaria chamomilla L.) treatment for generalized anxiety disorder: A randomized clinical trial
Keywords: Chamomile; Herbal medicine; Clinical trials; Generalized anxiety disorder; BAI; Beck Anxiety Inventory; CGI-S; Clinical Global Impression-Severity; GAD; Generalized Anxiety Disorder; HAM-A; Hamilton Anxiety Rating Scale; PGWBI; Psychological General Wel
A meta-analysis of the efficacy of vortioxetine in patients with major depressive disorder (MDD) and high levels of anxiety symptoms
Keywords: 5-HT; serotonin; AE; adverse event; ANCOVA; analysis of covariance; CGI-I; Clinical Global Impressions-Improvement; CGI-S; Clinical Global Impressions-Severity of Illness; DUL; duloxetine; EU; European Union; FAS; full analysis set; GAD; generalized a
Clinical trials of N-acetylcysteine in psychiatry and neurology: A systematic review
Keywords: ABC; Aberrant Behavior Checklist; AD; Alzheimer's disease; ADCS-ADL; Alzheimer's Disease Cooperative Study - Activities of Daily Living; ADHD; attention deficit hyperactivity disorder; ADL; Activities of Daily Living; ADP; adenosine diphosphate; AE; adv
Treatment of acute schizophrenia with paliperidone ER: Predictors for treatment response and benzodiazepine use
Keywords: BMI; body mass index; CGI-S; Clinical Global Impression-Severity; CI; confidence interval; DSM-IV; Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition; ER; extended release; OR; odds ratio; PANSS; Positive and Negative Syndrome Scale;
GSK3β, CREB, and BDNF in peripheral blood of patients with Alzheimer's disease and depression
Keywords: Aβ; amyloid-β; AD; Alzheimer's disease; Akt; protein kinase B; APP; amyloid precursor protein; BACE1; β-site APP-cleaving enzyme 1; BDNF; brain-derived neurotrophic factor; CGI-S; Clinical Global Impression-Severity scale; CREB; cAMP-response element
Effects of tapering of long-term benzodiazepines on cognitive function in patients with schizophrenia receiving a second-generation antipsychotic
Keywords: ANOVA; analysis of variance; BACS-J; Brief Assessment of Cognition in Schizophrenia Japanese-language version; CGI-S; Clinical Global Impression-Severity of illness scale; DIEPSS; Drug Induced Extrapyramidal Symptoms Scale; DSM-IV-TR; Diagnostic and Stati
Zonisamide produces weight loss in psychotropic drug-treated psychiatric outpatients
Keywords: GABA; gamma-aminobutyric acid; DSM-IV; Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition; BMI; body mass index; CGI-S; clinical global impression-severity; ANOVA; analysis of variance; Obesity; Psychotropic drugs; Weight; Zonisamide;
Venlafaxine or a second SSRI: Switching after treatment failure with an SSRI among depressed inpatients: A retrospective analysis
Keywords: MDD; major depressive disorder; SSRI; selective serotonin reuptake inhibitor; SNaRI; serotonin noradrenalin reuptake inhibitor; CGI-S; clinician global impression severity; AEs; adverse events; Depression; Inpatients; SSRI; Venlafaxine;
Association study between Disrupted-in-Schizophrenia-1 (DISC1) and Japanese patients with treatment-resistant schizophrenia (TRS)
Keywords: BPRS; Brief Psychiatric Rating Scale; CP; chlorpromazine; CGI-S; Clinical Global Impressions-Severity scale; CGI-I; Clinical Global Impressions-Improvement scale; DSM-IV; Diagnostic and Statistical Manual of Mental Disorders-IV; DISC1; Disrupted-in-Schizo
Improvements in both psychosis and motor signs in Parkinson's disease, and changes in regional cerebral blood flow after electroconvulsive therapy
Keywords: CGI-I; Clinical Global Impressions Improvement-scale; CGI-S; Clinical Global Impressions Severity-scale; ECT; electroconvulsive therapy; EEG; electroencephalography; fMRI; functional magnetic resonance imaging; MNI; Montreal Neurological Institute; PD; Pa
Psychopharmacological comparison of schizophrenia spectrum disorder with and without cannabis dependency
Keywords: CB1; cannabinoid receptor 1; CGI-S; Clinical Global Impression Scale; CGI-I; Clinical Global Improvement Scale; Cnbs; cannabis; HPDC; haloperidol decanoate; LAI; long acting injections; OR; odds ratio; Addiction; Cannabis; Psychosis; Psychopharmacotherapy
Effects of discontinuation of long-term biperiden use on cognitive function and quality of life in schizophrenia
Keywords: ANOVA; analysis of variance; BACS-J; Brief Assessment of Cognition in Schizophrenia in a Japanese-language version; CGI-S; Clinical Global Impression-Severity of illness scale; DIEPSS; Drug Induced Extrapyramidal Symptoms Scale; DSM-IV-TR; Diagnostic and
A double-blind study of paliperidone palmitate and risperidone long-acting injectable in adults with schizophrenia
Keywords: AIMS; Abnormal Involuntary Movement Scale; ANCOVA; analysis of covariance; BMI; body mass index; CGI-S; Clinical Global Impression-Severity; CI; confidence interval; DSM-IV; Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition; EPS; ext
Psychopharmacology in autism: An update
Keywords: ABC; Aberrant Behavior Checklist; ABC-C; Aberrant Behavior Checklist-Community; ABC-CV; Aberrant Behavior Checklist-Community Version; ABC-I; Aberrant Behavior Checklist-Irritability; ABC-H; Aberrant Behavior Checklist-Hyperactivity Subscale; ADHD; Attent
Armodafinil for Treatment of Excessive Sleepiness Associated With Shift Work Disorder: A Randomized Controlled Study
Keywords: CDR; Cognitive Drug Research; CGI-C; Clinical Global Impressions of Change; CGI-S; Clinical Global Impressions of Severity of Illness; KSS; Karolinska Sleepiness Scale; MSLT; Multiple Sleep Latency Test; nCPAP; nasal continuous positive airway pressure; O
Modafinil Improves Symptoms of Attention-Deficit/Hyperactivity Disorder across Subtypes in Children and Adolescents
Keywords: ADHD; Attention-deficit/hyperactivity disorder; ADHD-RS-IV; Attention-Deficit/Hyperactivity Disorder Rating Scale-IV; CGI-I; Clinical Global Impression of Improvement; CGI-S; Clinical Global Impression of Severity of Illness; CI; Confidence interval; CPRS
Quetiapine as monotherapy for social anxiety disorder: A placebo-controlled study
Keywords: SAD; Social Anxiety Disorder; BSPS; Brief Social Phobia Scale; CGI-I; Clinical Global Impression of Improvement Scale; CGI-S; Clinical Global Impression Severity Scale; SPIN; Social Phobia Inventory; SDI; Sheehan Disability Inventory; NNT; Number Needed t
Mirtazapine for patients with alcohol dependence and comorbid depressive disorders: A multicentre, open label study
Keywords: CGI-S; Clinical Global Impression-Severity; HDRS; Hamilton Depression Rating Scale; HARS; Hamilton Anxiety Rating Scale; ITT; Intent-to-treat population; LOCF; Last observation carried forward; OCDS; Obsessive Compulsive Drinking Scale; VAS; Visual Analog
Improvement in social functioning in outpatients with schizophrenia with prominent negative symptoms treated with olanzapine or risperidone in a 1 year randomized, open-label trial
Keywords: 5-HT; serotonin; CGI-S; Clinical Global Impression Scale of Severity; D; dopamine; DSM-IV; Diagnostic and Statistical Manual of Mental Disorders-Fourth Edition; GLM; generalized linear model; LOCF; last observation carried forward; LSM; least square mean;
Ropinirole in the Treatment of Patients With Restless Legs Syndrome: A US-Based Randomized, Double-Blind, Placebo-Controlled Clinical Trial
Keywords: AE; adverse event; CGI; Clinical Global Impression; CGI-I; CGI Improvement; CGI-S; CGI-Severity of Illness; CI; confidence interval; ECG; electrocardiogram; HADS; Hospital Anxiety and Depression Scale; IRLS; International Restless Legs Scale; ITT; intenti
Safety and effectiveness of olanzapine in monotherapy: A multivariate analysis of a naturalistic study
Keywords: BPRS; Brief Psychiatric Rating Scale; CA; conventional antipsychotics; CG; group of patients treated with conventional antipsychotics; CGI-S; Clinical Global Impression of Severity; EPS; extrapyramidal symptoms; ICD-10; International Classification of Dis